U.S. Wireless Telecom Stock News

The United States market has experienced a significant downturn, with a 29% drop over the last week and an 82% decline over the past year, though earnings are forecast to grow by 16% annually. In such challenging times, identifying stocks with strong fundamentals and growth potential can offer opportunities for investors looking to navigate these volatile conditions.

In the past week, the United States market has experienced a significant downturn with a 29% drop, contributing to an overall decline of 82% over the last year. In such volatile conditions, dividend stocks can offer some stability and income potential as investors look for companies with strong fundamentals and reliable earnings growth.

BlackRock, Inc. ( NYSE:BLK ) investors will be delighted, with the company turning in some strong numbers with its...

There's no doubt that money can be made by owning shares of unprofitable businesses. For example, biotech and mining...

We'd be surprised if Aehr Test Systems, Inc. ( NASDAQ:AEHR ) shareholders haven't noticed that the Chief Operating...

Kimberly-Clark (NasdaqGS:KMB) has outlined its executive leadership team and organizational structure for the combined company following the pending acquisition of Kenvue. The new structure is designed to guide how brands and business segments will operate once the transaction closes and regulatory approvals are secured. The announcement sets out who will lead the integration of Kenvue into Kimberly-Clark and how the enlarged business will be organized. Kimberly-Clark, known for its...

The Morning Bull - US Market Morning Update Friday, Apr, 17 2026 US stock futures are pointing slightly higher this morning, with key contracts on the S&P 500 and Nasdaq 100 up around 0.1% to 0.2%, as investors weigh firm bond yields against mixed economic signals. The US 10 year Treasury yield sits above 4.3%, which keeps borrowing costs elevated for households and companies. At the same time, US industrial production fell 0.5% in March while a regional factory scorecard, the Philadelphia...

Emerson Electric (NYSE:EMR) has entered a global reseller partnership with OPSWAT focused on cybersecurity for power and water infrastructure. The agreement will integrate OPSWAT's operational technology patch management tools into Emerson's Ovation Automation Platform. The partnership responds to rising cyber risks and evolving regulatory expectations for critical infrastructure operators worldwide. For investors watching Emerson Electric at a share price of $140.37, this new cybersecurity...

For anyone wondering whether Evercore's current share price lines up with its underlying worth, this article breaks down what the recent action might be telling you about value and risk. Evercore shares last closed at US$357.52, with returns of 6.7% over 7 days, 28.3% over 30 days, 1.8% year to date, 99.5% over 1 year, 204.1% over 3 years and 183.9% over 5 years. This provides plenty of price history to weigh against current expectations. Recent attention on Evercore has been driven by...

Slide Insurance Holdings' (NasdaqGS:SLDE) Chief Risk Officer has exercised stock options and sold all resulting shares, reducing direct ownership to zero. This transaction continues a pattern of six consecutive option exercises followed by full share liquidations. The executive still holds a significant number of outstanding options despite having no current direct shareholding. Slide Insurance Holdings, trading on the NasdaqGS under the ticker SLDE, most recently closed at $18.99. The...

If you have been wondering whether Northern Trust's recent share price reflects its underlying worth, this breakdown will help you separate price from value. Northern Trust's last close was US$156.77, with returns of 2.7% over 7 days, 14.6% over 30 days, 12.6% year to date, 82.0% over 1 year, 100.9% over 3 years, and 70.8% over 5 years. Recent coverage has focused on Northern Trust as a long established financial institution and how investor sentiment around financial services has been...

Wondering if CME Group at around US$296 per share still offers value, or if most of the opportunity has already been priced in. The stock has been relatively steady in the short term, with a 0.9% decline over 7 days and a 5.5% decline over 30 days, while returns sit at 9.8% year to date and 17.2% over the last year, and 77.1% over both 3 and 5 years. Recent attention on CME Group has centered on its role as a key exchange operator, with investors watching how trading activity and product mix...

Camden Property Trust agreed to a $53 million settlement in a major class action lawsuit over alleged use of rent setting software to coordinate rent increases. The settlement addresses Camden's historical use of RealPage's revenue management tools and related data practices across its multifamily portfolio. The agreement includes commitments on how Camden will use revenue management software and data going forward, with implications for compliance practices in the wider apartment...

Cheniere Energy (NYSE:LNG) announced a leadership change, with longtime Chairman G. Andrea Botta retiring from the board after 16 years. CEO Jack Fusco is set to assume the combined role of Chairman and CEO, concentrating executive and board leadership in a single position. Patricia Collawn has been appointed Lead Director, creating a defined counterbalance to the Chair role within the board structure. Cheniere Energy is a major US LNG exporter, so boardroom decisions can matter for how the...

If you are wondering whether Zscaler at US$134.33 is starting to look appealing or still priced for perfection, the numbers behind its valuation story are worth a closer look. The stock has had a bumpy ride, with a 9.9% gain over the last 7 days, a 13.9% decline over the last 30 days, a 39.1% decline year to date, and a 33.2% decline over the last year. The 3 year return sits at 33.7%, and the 5 year return at a 29.3% decline. Recent headlines around cybersecurity spending and cloud security...

If you are wondering whether Affirm Holdings at around US$60 per share represents compelling value or stretched expectations, the key is to look past the headlines and focus on what the numbers actually say about the stock. The share price closed at US$60.28, with returns of 23% over the past week, 26.7% over the past month, negative 18.6% year to date, and 43.2% over the last year. This naturally raises questions about both growth potential and changing risk perceptions. Recent news around...

Insight Enterprises recently filed a US$19.64 million shelf registration for 266,170 common shares tied to its employee stock ownership plan, and previously announced a one-time performance-based RSU inducement award valued at about US$10.00 million for new CEO Jack Azagury. Together, these equity moves highlight Insight’s focus on employee and executive ownership, while raising questions about future capital needs and dilution for existing shareholders. We’ll now examine how the new CEO’s...

ReNew Energy Global (RNW) is back in focus after commissioning about 2.4 GW of new renewable assets in fiscal 2026, which lifted total operating capacity to roughly 12.6 GW in India. See our latest analysis for ReNew Energy Global. The commissioning news arrived during a mixed period for the stock, with a 7 day share price return of 5.05% contrasting with a year to date share price decline of 14.85% and a 5 year total shareholder return decline of 50.10%. This suggests that recent momentum...

In early April 2026, Precigen Inc. reiterated that first-quarter sales of its lead respiratory treatment, PAPZIMEOS, are expected to exceed US$18,000,000, shortly after the Centers for Medicare & Medicaid Services granted the drug a permanent J-code (J3404) to streamline reimbursement and broaden patient access. This combination of a clearer reimbursement pathway and management’s confidence in PAPZIMEOS demand highlights how payer recognition can reinforce the company’s commercialization...

On April 6, 2026, HealthEquity, Inc. disclosed that it terminated Chief Technology Officer Eli Rosner’s employment without cause, effective April 17, 2026, and assigned Executive Vice President, Chief Product and Strategy Officer Sunil Rajasekar to oversee the technology organization. This shift places HealthEquity’s core technology, product, and strategy responsibilities under a single executive with extensive experience leading digital platforms at Billtrust, MINDBODY, eBay, Intuit, and...

If you are wondering whether Extra Space Storage is attractively priced or already fully valued, starting with a clear view of what you are paying for each future dollar of cash flow can help frame the decision. The share price recently closed at US$141.64, with returns of 1.7% over 7 days, 2.4% over 30 days, 8.1% year to date, 5.0% over 1 year, 6.3% over 3 years and 17.1% over 5 years. These figures can reshape how investors think about both potential and risk. Recent headlines around Extra...

Wondering if Olaplex Holdings at US$2.04 is a bargain or a value trap? This breakdown will help you size up what the current share price might be reflecting. The stock has posted returns of 0.5% over the last 7 days, 64.5% over the last 30 days, 51.1% year to date, 67.2% over the last year, and a 46.6% decline over 3 years, which signals that sentiment around the shares has shifted more than once. Recent headlines have focused on how traders are reacting to the sharp 30 day and 1 year...

Travelers Companies (TRV) has reported Q4 2025 total revenue of US$12.4b and net income of US$2.5b, equating to basic EPS of US$11.24, as investors look ahead to the Q1 2026 update. Over the past year, revenue moved from US$11.8b in Q1 2025 to US$12.4b in Q4 2025, while basic EPS ranged from US$1.73 to US$11.24 across those quarters. This provides a view of how earnings tracked alongside a 12.8% net margin on a trailing twelve month basis. Against that backdrop, the latest results keep the...

If you are trying to work out whether ResMed's share price makes sense right now, a good starting point is understanding what the current market price is actually implying about the business. The stock most recently closed at US$224.72, with returns of a 1.4% decline over 7 days, a 3.8% decline over 30 days, an 8.2% decline year to date, and gains of 6.5% over 1 year, 2.8% over 3 years and 12.7% over 5 years. Recent coverage has focused on ResMed's position in the medical equipment space and...